{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:35:00Z","timestamp":1787726100856,"version":"build-2784847793"},"reference-count":111,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"unspecified","delay-in-days":491,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"agencies in the public, commercial, or not-for-profit sectors"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2020,3,3]]},"DOI":"10.1080\/21645515.2019.1665453","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T15:43:21Z","timestamp":1568735001000},"page":"645-653","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":32,"title":["Rationale for the development of an Alzheimer\u2019s disease vaccine"],"prefix":"10.1080","volume":"16","author":[{"given":"Ping","family":"Kwan","sequence":"first","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Shatin, Hong Kong SAR, P.R. China"]},{"name":"The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Konno","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Shatin, Hong Kong SAR, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Yan","family":"Chan","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Shatin, Hong Kong SAR, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-9355","authenticated-orcid":false,"given":"Larry","family":"Baum","sequence":"additional","affiliation":[{"name":"The Chinese University of Hong Kong","place":["Shatin, Hong Kong SAR, P.R. China"]},{"name":"The University of Hong Kong","place":["Pokfulam, Hong Kong SAR, P.R. China"]},{"name":"The University of Hong Kong","place":["Pokfulam, Hong Kong SAR, P.R. China"]},{"name":"The University of Hong Kong","place":["Pokfulam, Hong Kong SAR, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"e_1_3_2_2_1","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer A.","year":"1907","unstructured":"Alzheimer A. \u00dcber eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift Fur Psychiatrie Und Psychisch-gerichtliche Medizin. 1907;64:146\u201348.","journal-title":"Allgemeine Zeitschrift Fur Psychiatrie Und Psychisch-gerichtliche Medizin"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b158"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2000_3991"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.02.040"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/15680266113139990143"},{"key":"e_1_3_2_7_1","unstructured":"Patterson C. World Alzheimer report 2018 [Internet]. 2018. [Accessed 2019 Oct 4] https:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2018.pdf."},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3810169"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/325733a0"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2949367"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/34602"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/375754a0"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7638622"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/376775a0"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(84)80190-4"},{"key":"e_1_3_2_16_1","first-page":"395","volume-title":"Handbook of clinical neurology","author":"Carmona S","year":"2018","unstructured":"Carmona S, Hardy J, Guerreiro R. The genetic landscape of Alzheimer disease [Internet]. In: Daniel H. Geschwind, Henry L. Paulson, and Christine Klein, editor. Handbook of clinical neurology. Elsevier;2018 [Accessed 2018 Dec 28]. p. 395\u2013408. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444640765000260."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-864"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.008"},{"key":"e_1_3_2_19_1","first-page":"79","volume-title":"Progress in molecular biology and translational science, David B. Teplow, editor","author":"Bertram L","year":"2012","unstructured":"Bertram L, Tanzi RE. The genetics of Alzheimer\u2019s disease [Internet]. In: David B. Teplow, editor. Progress in molecular biology and translational science, David B. Teplow, editor. Elsevier;2012 [Accessed 2018 Dec 26]. p. 79\u2013100. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780123858832000084."},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00069a001"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1566067"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606210"},{"key":"e_1_3_2_23_1","first-page":"303","volume-title":"Handbook of clinical neurology","author":"Walker LC","year":"2018","unstructured":"Walker LC. Prion-like mechanisms in Alzheimer disease [Internet]. In: Human Prion Diseases, editors. Handbook of clinical neurology. Elsevier; 2018 [Accessed 2019 Jan 6]. p. 303\u201319. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444639455000167."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103081"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-018-0139-3"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.5847"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.5.1977"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002156"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-175976"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00114\/abstract"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.040089"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2013.0433"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.10.012"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000159740.16984.3C"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz142"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506209103"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt237"},{"key":"e_1_3_2_38_1","unstructured":"U.S. National Library of Medicine. Safety and immunogenicity of repeated doses of aBvac40 in patients with a-MCI or Vm-AD [Internet]. ClinicalTrials.org. 2018 [Accessed 2019 Oct 4]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03461276."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2016.06.009"},{"key":"e_1_3_2_40_1","first-page":"242","article-title":"The Alzheimer\u2019s prevention initiative generation program: evaluating CNP520 efficacy in the prevention of Alzheimer\u2019s disease","volume":"4","author":"Lopez Lopez C","year":"2017","unstructured":"Lopez Lopez C, Caputo A, Liu F, Riviere ME, Rouzade-Dominguez M-L, Thomas RG, Langbaum JB, Lenz R, Reiman EM, Graf A, et al. The Alzheimer\u2019s prevention initiative generation program: evaluating CNP520 efficacy in the prevention of Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2017;4:242\u201346.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0340-8"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-015-0108-3"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2016.12.003"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205014666170117101537"},{"key":"e_1_3_2_45_1","first-page":"103","article-title":"Results from a phase II study to assess the clinical and immunological activity of AFFITOPE\u00ae AD02 in patients with early Alzheimer\u2019s disease","volume":"2","author":"Schneeberger A","year":"2015","unstructured":"Schneeberger A, Hendrix S, Mandler M, Ellison N, B\u00fcrger V, Brunner M, Fr\u00f6lich L, Mimica N, Hort J, Rainer M, et al. Results from a phase II study to assess the clinical and immunological activity of AFFITOPE\u00ae AD02 in patients with early Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2015;2:103\u201314.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_2_46_1","unstructured":"U.S. National Library of Medicine. A study of V950 in people with Alzheimer disease (V950-001 AM7) [Internet]. ClinicalTrials.org. 2015 [Accessed 2019 Oct 4]. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00464334."},{"key":"e_1_3_2_47_1","unstructured":"U.S. National Library of Medicine. Study with Lu AF20513 in patients with mild Alzheimer\u2019s disease (AD) or mild cognitive impairment (MCI) due to AD [Internet]. ClinicalTrials.org. 2019 [Accessed 2019 Oct 4]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03819699."},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152471"},{"key":"e_1_3_2_49_1","unstructured":"Rafii MS. Active immunotherapy for cognitive decline in adults with down syndrome [Internet] [Accessed 2019 Oct 4]. http:\/\/grantome.com\/grant\/NIH\/R01-AG047922-01."},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150376"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2017.03.005"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0441-4"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-019-0664-z"},{"key":"e_1_3_2_54_1","unstructured":"AC Immune SA. AC immune initiates Ph1b\/2a study of anti-phospho-tau vaccine in Alzheimer\u2019s disease [Internet]. AC Immune. 2019 [Accessed 2019 Oct 4]. https:\/\/ir.acimmune.com\/news-releases\/news-release-details\/ac-immune-initiates-ph1b2a-study-anti-phospho-tau-vaccine?field_nir_news_date_value[min]=2019."},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2761"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2763"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051068"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0406-x"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304839"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098153"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312889"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705971"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2017.04.003"},{"key":"e_1_3_2_64_1","unstructured":"McCaffrey P. Second look at BAN2401 data still positive despite snafu [Internet]. Alzforum.org\/news\/conference-coverage\/second-look-ban2401-data-still-positive-despite-snafu. 2018. https:\/\/www.alzforum.org\/news\/conference-coverage\/second-look-ban2401-data-still-positive-despite-snafu."},{"key":"e_1_3_2_65_1","unstructured":"Rogers MB. Four immunotherapies now banish amyloid from the brain [Internet]. Alzforum. 2018 [Accessed 2019 Oct 4]. https:\/\/www.alzforum.org\/news\/conference-coverage\/four-immunotherapies-now-banish-amyloid-brain."},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2016.1241232"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0318-y"},{"key":"e_1_3_2_68_1","unstructured":"Haeberlein SB O\u2019Gorman J Chiao P et al. Clinical development of aducanumab an anti-a\u03b2 human monoclonal antibody being investigated for the treatment of early Alzheimer\u2019s disease. 2017 [Accessed 2019 Jan 4]. http:\/\/www.jpreventionalzheimer.com\/all-issues.html?article=364."},{"key":"e_1_3_2_69_1","unstructured":"Aducanumab. [Internet] Alzforum.org\/therapeutics\/aducanumab [Accessed 2019 Oct 4]. https:\/\/www.alzforum.org\/therapeutics\/aducanumab."},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0205-1"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0115-2"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1554646"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005550"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25513"},{"key":"e_1_3_2_76_1","unstructured":"Rogers MB. Roche pulls plug on two phase 3 trials of crenezumab [Internet]. Alzforum. 2019 [Accessed 2019 Oct 4]. https:\/\/www.alzforum.org\/news\/research-news\/roche-pulls-plug-two-phase-3-trials-crenezumab."},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.03.035"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202753"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-3-247"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2013.01.002"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007941"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.03.009"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14036"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1918-8"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.09.027"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14079"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160152"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160488"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00362\/full"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700009053"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3040"},{"key":"e_1_3_2_92_1","unstructured":"Rogers MB. Herpes triggers amyloid\u2014could this virus fuel Alzheimer\u2019s? [Internet]. Alzforum. 2018 [Accessed 2019 Oct 4]. https:\/\/www.alzforum.org\/news\/research-news\/herpes-triggers-amyloid-could-virus-fuel-alzheimers."},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(01)00342-6"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf1059"},{"key":"e_1_3_2_95_1","article-title":"Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits","volume":"10","author":"Wu Y","year":"2019","unstructured":"Wu Y, Du S, Johnson JL, Tung H-Y, Landers CT, Liu Y, Seman BG, Wheeler RT, Costa-Mattioli M, Kheradmand F, et al. Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits. Nat Commun [Internet]. 2019 [Accessed 2019 Jan 7];10. http:\/\/www.nature.com\/articles\/s41467-018-07991-4.","journal-title":"Nat Commun"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160607"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1388-y"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756286418791107"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.06.030"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.05.023"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100044115"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708714"},{"key":"e_1_3_2_103_1","unstructured":"Lovheim H. Feasibility and effects of valaciclovir treatment in persons with early Alzheimer\u2019s disease (VALZ-Pilot) [Internet]. 2016 [Accessed 2019 Oct 4]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02997982."},{"key":"e_1_3_2_104_1","unstructured":"Devanand DP. Anti-viral therapy in Alzheimer\u2019s disease [Internet]. 2017 [Accessed 2019 Oct 4]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03282916."},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16157.1"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8346"},{"key":"e_1_3_2_107_1","unstructured":"Rosenthal E. The price of prevention: vaccine costs are soaring [Internet]. New York Times. 2014; A1. https:\/\/www.nytimes.com\/2014\/07\/03\/health\/Vaccine-Costs-Soaring-Paying-Till-It-Hurts.html."},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70169-8"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.07.008"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4401-10.2011"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-010-9414-5"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001740107"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1665453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:10:50Z","timestamp":1748963450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1665453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,3]]}},"alternative-id":["10.1080\/21645515.2019.1665453"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1665453","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-05-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}